Ranjan Sur - Concepedia

Author

Ranjan Sur

University of the Witwatersrand ORCID

Also Known As

D I Williams, R K Sur, R SUR, R Sur, R. K. Sur, R. SUR, R. Sur, R.K. Sur, Ranjan K Sur, Ranjan K. Sur

Publications

8.9K

Citations

H-Index

Concepts

All Affiliations

University of the Witwatersrand McMaster University Juravinski Cancer Centre Johannesburg Hospital Post Graduate Institute of Medical Education and Research

About

Ranjan Sur is an author at University of the Witwatersrand specializing in medicine, radiation therapy, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	20	3K
2	Health Sciences	10	10	798
3	Public Health	1	1	15
4	Epidemiology	1	1	15
5	Gastroenterology	1	1	46

Ranjan Sur

Publications

8.6K

Citations

H-Index

Page 1

	Year	Citations
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck James A. Bonner, Paul M. Harari, J. Giralt, New England Journal of Medicine	2006	5.1K
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival James A. Bonner, Paul M. Harari, J. Giralt, The Lancet Oncology Advanced HeadNeck CancerRadiation TherapyMedicineRandomised Trial	2009	2K
Palliative thoracic radiotherapy in lung cancer: An American Society for Radiation Oncology evidence-based clinical practice guideline George Rodrigues, Gregory M.M. Videtic, Ranjan Sur, Practical Radiation Oncology	2011	205
The spectrum of HIV-1 related cancers in South Africa Freddy Sitas, Rosana Pacella, Henri Carrara, International Journal of Cancer	2000	165
Motexafin Gadolinium Combined With Prompt Whole Brain Radiotherapy Prolongs Time to Neurologic Progression in Non–Small-Cell Lung Cancer Patients With Brain Metastases: Results of a Phase III Trial Minesh P. Mehta, William R. Shapiro, See Phan, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyTreatment StrategiesNeurologic ProgressionRadiation TherapyMedicine	2008	164
Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma—an International Atomic Energy Agency study Ranjan Sur, C V Levin, Bernard Donde, International Journal of Radiation OncologyBiologyPhysics Advanced EsophagealSole ModalityEsophageal CancerRadiation TherapyHdr Brachytherapy	2002	149
Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer Ranjan Sur, Bernard Donde, Victor Levin, International Journal of Radiation OncologyBiologyPhysics Advanced Esophageal CancerNeuro-oncologySurgical OncologyEsophageal CancerRadiation Therapy	1998	128
Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: A prospective multi-centre randomized trial of the International Atomic Energy Agency Eduardo Rosenblatt, Glenn Jones, Ranjan Sur, Radiotherapy and Oncology Esophageal CancerRadiation TherapyMedicineIntra-luminal BrachytherapyBrachytherapy	2010	102
Radiation therapy of esophageal cancer: Role of high dose rate brachytherapy Ranjan Sur, Deepinder Singh, Suresh C. Sharma, International Journal of Radiation OncologyBiologyPhysics Surgical OncologyRadiation MedicineEsophageal CancerRadiation TherapyMedicine	1992	89
Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer Ranjan Sur, Bernard Donde, Conrad Falkson, Brachytherapy Advanced Esophageal CancerSurgical OncologyEsophageal CancerRadiation TherapyMedicine	2004	66

Page 1